Abbott | Neuromodulation

There was a lot to take in at #PSPS2026! From a decade of impact with BurstDR™ stimulation to the next generation of SCS therapy with FlexBurst360™ therapy, we showcased innovations across our neuromodulation portfolio designed to help address the needs of patients living with chronic pain. Thank you to everyone who connected with us throughout the meeting, including those who joined our faculty dinner. We appreciate the conversations and shared commitment to advancing chronic pain care. Important Safety Info: https://bit.ly/4ypxGdJ #PSPSAnnualMeeting #Neuromodulation MAT-2680239 v1.0 | Item approved for global use.

Advancing neuromodulation takes innovation, collaboration, and close partnerships with the clinicians who understand patients’ evolving needs. We’re proud to partner with advanced practice providers (APPs) who play an important role in patient care. We value the opportunity to learn from their experiences, exchange perspectives, and work together to provide better care for people living with chronic pain. ➡️ Hear directly from APPs Ashley Comer, Morteza Rabii DNP, APRN, AGPCNP-BC, and Casey Grillo about why they partner with us and what makes that collaboration meaningful. #Neuromodulation #ChronicPain Important Safety Info: bit.ly/4gL7p46 MAT-2681596 v1.0 | Item approved for use in the US.

At the heart of our work in neuromodulation is a shared commitment to improving care for people living with chronic pain. From clinical collaboration to ongoing support, our team works alongside physicians with a shared goal of meeting patient needs. ➡️ Hear from physicians Jackie Weisbein, Pankaj Mehta MD, Tim Deer, MD, and Steven Falowski about why they partner with us and how working together helps support the people in their care. Important Safety Info: bit.ly/4gL7p46 #Neuromodulation #ChronicPain MAT-2681595 v1.0 | Item approved for use in the US.

We had a meaningful evening of conversation at #PSPS2026! Our TINS Dinner brought together Drs. Pankaj Mehta MD and Steven Falowski to discuss a full portfolio approach to chronic pain management, including perspectives on our BurstDR™ stimulation, FlexBurst360™ therapy, DRG therapy, and the latest advancements designed to expand access to care. We’re proud to be part of the ongoing conversation around innovation in chronic pain management. Thank you to all who joined us. Important Safety Info: https://bit.ly/4ypxGdJ #PSPSAnnualMeeting #Neuromodulation MAT-2680844 v1.0 | Item approved for use in the US.

Dorsal root ganglion (DRG) therapy takes a targeted approach to chronic pain. We’re showing you how it works at #ISPN2026. Visit our booth for an overview of the Proclaim ™DRG Neurostimulation System and a hands-on demo of the Next-Generation Delivery System. Save the info! ⬇️ Important Safety Info: https://bit.ly/4yJtcin #DRGTherapy #ChronicPain #Neuromodulation

Innovation that matters. Outcomes that endure. That’s the foundation of our chronic pain portfolio — and the focus of our #ISPN2026 TINS dinner. Hear an expert panel discuss the origin of our BurstDR™ stimulation waveform, the evolution to FlexBurst360™ therapy, and how our solutions may help you target and tailor therapy for patients living with chronic pain. Sign up: https://bit.ly/4jyLIWu Dirk De Ridder | Steven Falowski | Tim Deer, MD | Dawood Sayed | Pedram Tabatabaei Important Safety Info: https://bit.ly/4yJtcin #ChronicPain #Innovation #Neuromodulation

That’s a wrap on #MDSCongress! It was an inspiring time to connect with the movement disorder community, share perspectives, and explore the latest thinking shaping the future of neuromodulation. Thank you to everyone who stopped by and contributed to the engaging conversations at our booth. We look forward to carrying these insights forward as we continue working to advance care for people living with movement disorders. Important Safety Info: https://bit.ly/4yJtcin #Neuromodulation #MovementDisorders MAT-2679681 v1.0 | Item approved for global use.

Discover a comprehensive approach to chronic pain management at #ISPN2026. Our lunch symposium will explore the clinical evidence supporting our spinal cord stimulation and dorsal root ganglion therapies, as well as how our connected care platform can help transform the care experience for your patients. Steven Falowski | Tim Deer, MD| Pankaj Mehta MD | Naoufel Ouerchefani Add us to your calendar: https://bit.ly/4ykJIp3 Important Safety Info: https://bit.ly/4yJtcin #ChronicPainManagement #Neuromodulation

Innovation doesn’t end with technology. It continues through the education and support that help healthcare professionals put innovation into practice. From physician education and peer learning to responsive support in the clinic, our deep brain stimulation (DBS) therapy enables healthcare professionals at every turn to ultimately deliver life-changing technology to patients. For the past decade, our impact has been defined by more than what we've developed. It's also reflected in how we've supported the people delivering care. Watch the video to hear healthcare providers share their perspectives on DBS education and support. Drew Falconer, MD | Michael Soileau, MD FAAN | Meredith Hatcher, PA-C, CMRD | Andrew Imbus, PA-C | Wes O'Brian Important Safety Info: bit.ly/4gL7p46 #DBS #Neuromodulation MAT-2678704 v3.0 | Item approved for use in the US.

We’re heading to Amsterdam for #ISPN2026! Our sessions will explore the latest clinical evidence and outcomes behind our chronic pain portfolio and connected care solutions, emphasizing how our tools can support your practice and empower your patients throughout their neurostimulation journey. Join us: https://bit.ly/4qW755Z Important Safety Info: https://bit.ly/4yJtcin #ChronicPainCare #SpinalCordStimulation #DRGTherapy